AXITINIB vs AZILSARTAN KAMEDOXOMIL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
AXITINIB vs AZILSARTAN KAMEDOXOMIL: Safety Overview
| Metric | AXITINIB | AZILSARTAN KAMEDOXOMIL |
|---|---|---|
| Total FAERS Reports | 15,863 | 1,000 |
| Deaths Reported | 3,141 | 52 |
| Death Rate | 19.8% | 5.2% |
| Hospitalizations | 4,050 | 199 |
| Average Patient Age | 65.5 yrs | 67.5 yrs |
| % Female Patients | 29.4% | 52.6% |
| FDA Approval Date | Jan 27, 2012 | Feb 25, 2011 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | Pharma Packaging Solutions, LLC dba T... |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |